We are live on ! Find out more
REPL icon

Replimune Group

107 hedge funds and large institutions have $665M invested in Replimune Group in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 13

34% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 29

8% more funds holding

Funds holding: 99107 (+8)

0.06% more ownership

Funds ownership: 82.8%82.86% (+0.06%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

37% less capital invested

Capital invested by funds: $1.05B → $665M (-$385M)

Holders
107
Holders Change
+8
Holders Change %
+8.08%
% of All Funds
1.69%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
21
Increased
39
Reduced
29
Closed
13
Calls
$219K
Puts
Net Calls
+$219K
Net Calls Change
+$219K
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$3.67M +$131K +6,953 +3%
SFM
27
Sphera Funds Management
Israel
$3.61M +$4.01M +212,640 New
Renaissance Technologies
28
Renaissance Technologies
New York
$3.58M +$3.1M +164,400 +352%
Two Sigma Advisers
29
Two Sigma Advisers
New York
$3.31M +$1.32M +69,700 +56%
IHAM
30
Integral Health Asset Management
New York
$2.8M +$1.23M +65,000 +65%
Ensign Peak Advisors
31
Ensign Peak Advisors
Utah
$2.69M -$17.2M -912,041 -85%
Goldman Sachs
32
Goldman Sachs
New York
$2.4M +$685K +36,326 +35%
PAM
33
Panagora Asset Management
Massachusetts
$2.35M +$286K +15,169 +12%
Deutsche Bank
34
Deutsche Bank
Germany
$2.33M +$2.22M +117,655 +597%
Federated Hermes
35
Federated Hermes
Pennsylvania
$2.16M +$2.4M +127,321 New
TD Asset Management
36
TD Asset Management
Ontario, Canada
$2M -$205K -10,838 -8%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$1.85M -$7.66K -406 -0.4%
N
38
Nuveen
North Carolina
$1.76M +$482K +25,569 +30%
Rafferty Asset Management
39
Rafferty Asset Management
New York
$1.71M +$605K +32,042 +47%
OCM
40
Osterweis Capital Management
California
$1.68M -$974K -51,615 -34%
UBS Group
41
UBS Group
Switzerland
$1.6M +$595K +31,507 +50%
SG Americas Securities
42
SG Americas Securities
New York
$1.55M +$438K +23,199 +34%
GCP
43
GSA Capital Partners
United Kingdom
$1.48M +$1.64M +87,124 New
CSS
44
Cubist Systematic Strategies
Connecticut
$1.34M +$1M +53,215 +209%
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.33M +$1.18M +62,423 +387%
NFGH
46
Nan Fung Group Holdings
Hong Kong
$1.26M +$1.41M +74,479 New
Bank of America
47
Bank of America
North Carolina
$1.23M +$970K +51,395 +243%
Swiss National Bank
48
Swiss National Bank
Switzerland
$847K +$71.7K +3,800 +8%
Qube Research & Technologies (QRT)
49
Qube Research & Technologies (QRT)
United Kingdom
$834K +$926K +49,090 New
Susquehanna International Group
50
Susquehanna International Group
Pennsylvania
$833K -$243K -12,902 -21%

REPL Hedge Fund Activity: Q1 2022 in Review

107 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q1 2022, worth a combined $665M — down 37% from $1.05B a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new REPL positions and 13 closed out — a net gain of 8 holders — while 39 added to existing stakes and 29 trimmed.

The largest buyer was Baker Bros. Advisors, adding an estimated $19.2M. The largest seller was Loomis, Sayles & Company, exiting entirely with an estimated $30.1M sold.

  • 107 institutional investors held Replimune Group (REPL) as of Q1 2022, up from 99 in Q4 2021.
  • Funds reported $665M of Replimune Group stock for Q1 2022, down 37% quarter-over-quarter.
  • 21 funds opened new Replimune Group positions in Q1 2022 and 13 closed out, a net change of +8 holders.
  • The largest Replimune Group buyer in Q1 2022 was Baker Bros. Advisors, an estimated $19.2M added.
  • The largest Replimune Group seller in Q1 2022 was Loomis, Sayles & Company, an estimated $30.1M sold.

Based on aggregated 13F filings for Q1 2022.